Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1

Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1


Lead sponsor: TriHealth Inc.

Source TriHealth Inc.
Brief Summary

The goal of this study is to assess the health literacy level of patients enrolled in the HOPE program, identify any gaps in their knowledge of hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.

Detailed Description

The study will compare the effectiveness of providing a pamphlet and expert education compared to providing a pamphlet only. The information gained in completing this study will help the medical community improve patient education on the disease and specifically understand how the medical community can best serve pregnant patients with opiate dependence burdened by Hepatitis C.

Overall Status Completed
Start Date July 20, 2017
Completion Date August 26, 2019
Primary Completion Date August 26, 2019
Study Type Observational
Primary Outcome
Measure Time Frame
Discovering the gaps in patients' knowledge of Hepatitis C 2 months
Enrollment 8

Intervention type: Other

Intervention name: Qualitative Interview

Description: Complete 6 open-ended qualitative questions on patients in the HOPE program to assess basic current understanding about Hepatitis C and topics of interest that patients in the HOPE program would like to learn more about.


Sampling method: Probability Sample


Inclusion Criteria

- The study will include patients with and without Hepatitis C diagnosis.

- Patients will be recruited at their routine prenatal and post-partum visits.

- Patients who speak and understand English

Exclusion Criteria:

- Patients under the age of the 18 years

Gender: Female

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: Accepts Healthy Volunteers

Overall Official
Last Name Role Affiliation
Michael Marcotte, MD Principal Investigator TriHealth Inc.
facility Good Samaritan Hospital
Location Countries

United States

Verification Date

August 2019

Responsible Party

Responsible party type: Sponsor

Has Expanded Access No
Condition Browse
Patient Data No
Study Design Info

Observational model: Cohort

Time perspective: Prospective

Source: ClinicalTrials.gov